These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24749408)

  • 1. Nanoencapsulation of olanzapine increases its efficacy in antipsychotic treatment and reduces adverse effects.
    Dimer FA; Ortiz M; Pase CS; Roversi K; Friedrich RB; Pohlmann AR; Burger ME; Guterres SS
    J Biomed Nanotechnol; 2014 Jun; 10(6):1137-45. PubMed ID: 24749408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoencapsulation Improves Relative Bioavailability and Antipsychotic Effect of Olanzapine in Rats.
    Dimer FA; Pigatto MC; Boque CA; Pase CS; Roversi K; Pohlmann AR; Burger ME; Rates MK; Dalla Costa T; Guterres SS
    J Biomed Nanotechnol; 2015 Aug; 11(8):1482-93. PubMed ID: 26295148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects.
    Joseph E; Reddi S; Rinwa V; Balwani G; Saha R
    Eur J Pharm Sci; 2017 Jun; 104():315-325. PubMed ID: 28408348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucoadhesive Amphiphilic Methacrylic Copolymer-Functionalized Poly(ε-caprolactone) Nanocapsules for Nose-to-Brain Delivery of Olanzapine.
    Fonseca FN; Betti AH; Carvalho FC; Gremião MP; Dimer FA; Guterres SS; Tebaldi ML; Rates SM; Pohlmann AR
    J Biomed Nanotechnol; 2015 Aug; 11(8):1472-81. PubMed ID: 26295147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of rheology and release profiles of olanzapine-loaded lipid-core nanocapsules in thermosensitive hydrogel.
    Dimer FA; Pohlmann AR; Guterres SS
    J Nanosci Nanotechnol; 2013 Dec; 13(12):8144-53. PubMed ID: 24266207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol-loaded polysorbate-coated polymeric nanocapsules increase its efficacy in the antipsychotic treatment in rats.
    Benvegnú DM; Barcelos RC; Boufleur N; Reckziegel P; Pase CS; Ourique AF; Beck RC; Bürger ME
    Eur J Pharm Biopharm; 2011 Feb; 77(2):332-6. PubMed ID: 21168486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DoE based Olanzapine loaded poly-caprolactone nanoparticles decreases extrapyramidal effects in rodent model.
    Joseph E; Reddi S; Rinwa V; Balwani G; Saha R
    Int J Pharm; 2018 Apr; 541(1-2):198-205. PubMed ID: 29474898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
    Perez-Iglesias R; Crespo-Facorro B; Amado JA; Garcia-Unzueta MT; Ramirez-Bonilla ML; Gonzalez-Blanch C; Martinez-Garcia O; Vazquez-Barquero JL
    J Clin Psychiatry; 2007 Nov; 68(11):1733-40. PubMed ID: 18052567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects associated with atypical antipsychotic treatment in the developmentally disabled.
    McKee JR; Bodfish JW; Mahorney SL; Heeth WL; Ball MP
    J Clin Psychiatry; 2005 Sep; 66(9):1161-8. PubMed ID: 16187775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor antagonist compounds co-administration in female rats.
    Lazzari P; Serra V; Marcello S; Pira M; Mastinu A
    Eur Neuropsychopharmacol; 2017 Jul; 27(7):667-678. PubMed ID: 28377074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment.
    Zanotto-Filho A; Coradini K; Braganhol E; Schröder R; de Oliveira CM; Simões-Pires A; Battastini AM; Pohlmann AR; Guterres SS; Forcelini CM; Beck RC; Moreira JC
    Eur J Pharm Biopharm; 2013 Feb; 83(2):156-67. PubMed ID: 23219677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine.
    Newcomer JW; Campos JA; Marcus RN; Breder C; Berman RM; Kerselaers W; L'italien GJ; Nys M; Carson WH; McQuade RD
    J Clin Psychiatry; 2008 Jul; 69(7):1046-56. PubMed ID: 18605811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
    Meltzer HY; Bobo WV; Roy A; Jayathilake K; Chen Y; Ertugrul A; Anil Yağcioğlu AE; Small JG
    J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.
    Simpson MM; Goetz RR; Devlin MJ; Goetz SA; Walsh BT
    J Clin Psychiatry; 2001 Sep; 62(9):694-700. PubMed ID: 11681765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol-loaded polysorbate-coated polymeric nanocapsules decrease its adverse motor side effects and oxidative stress markers in rats.
    Benvegnú DM; Barcelos RC; Boufleur N; Pase CS; Reckziegel P; Flores FC; Ourique AF; Nora MD; da Silva Cde B; Beck RC; Bürger ME
    Neurochem Int; 2012 Oct; 61(5):623-31. PubMed ID: 22750274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats.
    Frozza RL; Bernardi A; Paese K; Hoppe JB; da Silva T; Battastini AM; Pohlmann AR; Guterres SS; Salbego C
    J Biomed Nanotechnol; 2010 Dec; 6(6):694-703. PubMed ID: 21361135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain targeting of olanzapine via intranasal delivery of core-shell difunctional block copolymer mixed nanomicellar carriers: in vitro characterization, ex vivo estimation of nasal toxicity and in vivo biodistribution studies.
    Abdelbary GA; Tadros MI
    Int J Pharm; 2013 Aug; 452(1-2):300-10. PubMed ID: 23684658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects.
    Skrede S; Martins L; Berge RK; Steen VM; López M; Fernø J
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):91-104. PubMed ID: 23919889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
    Simpson GM; Glick ID; Weiden PJ; Romano SJ; Siu CO
    Am J Psychiatry; 2004 Oct; 161(10):1837-47. PubMed ID: 15465981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.